(Q44238910)

1 December 2017

title

Effects of creatine supplementation on muscle wasting and glucose homeostasis in rats treated with dexamethasone (English)

1 reference

1 December 2017

1 reference

8

1 reference

Antonio Herbert Lancha Junior

1 December 2017

Bruno Gualano

2

0 references

1 reference

ORCID Public Data File 2021

author name string

Humberto Nicastro

1

1 reference

1 December 2017

Wilson Max Almeida Monteiro de Moraes

3

1 reference

1 December 2017

Vitor de Salles Painelli

4

1 reference

1 December 2017

Claudia Ribeiro da Luz

5

1 reference

1 December 2017

Andre dos Santos Costa

6

1 reference

1 December 2017

Fabiana de Salvi Guimarães

7

1 reference

1 December 2017

Patricia Chakur Brum

9

1 reference

1 December 2017

Antonio Herbert Lancha

10

1 reference

1 December 2017

language of work or name

1 reference

5 March 2011

1 reference

1 December 2017

1 reference

1 December 2017

volume

42

1 reference

1 December 2017

issue

5

1 reference

1 December 2017

page(s)

1695-1701

1 reference

Changes in serum ghrelin concentration following biliopancreatic diversion for obesity.

1 December 2017

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS00726-011-0871-9

Dexamethasone induction of hypertension and diabetes is PPAR-alpha dependent in LDL receptor-null mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00726-011-0871-9

Creatine intake attenuates corticosteroid-induced impairment of voluntary running in hamsters.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00726-011-0871-9

The E3 Ligase MuRF1 degrades myosin heavy chain protein in dexamethasone-treated skeletal muscle

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00726-011-0871-9

Glucocorticoid regulation of insulin receptor and substrate IRS-1 tyrosine phosphorylation in rat skeletal muscle in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00726-011-0871-9

Effects of creatine supplementation on glucose tolerance and insulin sensitivity in sedentary healthy males undergoing aerobic training.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00726-011-0871-9

Exploring the therapeutic role of creatine supplementation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00726-011-0871-9

Glucocorticoids and muscle catabolism

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00726-011-0871-9

Influence of systemic hypotension on skeletal muscle ischemia-reperfusion injury after 4-hour tourniquet application

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00726-011-0871-9

Creatine treatment in muscle disorders: a meta-analysis of randomised controlled trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00726-011-0871-9

No effect of creatine supplementation on human myofibrillar and sarcoplasmic protein synthesis after resistance exercise

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00726-011-0871-9

Effect of creatine supplementation on creatine and glycogen content in rat skeletal muscle

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00726-011-0871-9

Effect of oral creatine supplementation on human muscle GLUT4 protein content after immobilization

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00726-011-0871-9

Dietary supplementation with creatine monohydrate prevents corticosteroid-induced attenuation of growth in young rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00726-011-0871-9

Creatine monohydrate increases strength in patients with neuromuscular disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00726-011-0871-9

Histological assessment of intermediate- and long-term creatine monohydrate supplementation in mice and rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00726-011-0871-9

The glucocorticoid receptor and FOXO1 synergistically activate the skeletal muscle atrophy-associated MuRF1 gene.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00726-011-0871-9

Creatine for treating muscle disorders

21 January 2018

1 reference

COCI

https://opencitations.net/index/api/v1/citations/10.1002/14651858.CD004760.PUB2

10.1007/S00726-011-0871-9

9 March 2024

Identifiers

DOI

1 reference

1 December 2017

1 reference